Authors:
Xie, XM
Zhao, XQ
Liu, YF
Young, CYF
Tindall, DJ
Slawin, KM
Spencer, DM
Citation: Xm. Xie et al., Robust prostate-specific expression for targeted gene therapy based on thehuman kallikrein 2 promoter, HUM GENE TH, 12(5), 2001, pp. 549-561
Citation: Dj. Tindall et Pj. Scardino, State of research for prostate cancer: Excerpt from the report of the Prostate Cancer Progress Review Group, UROLOGY, 57(4A), 2001, pp. 28-30
Authors:
Huang, H
Cheville, JC
Pan, YQ
Roche, PC
Schmidt, LJ
Tindall, DJ
Citation: H. Huang et al., PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression, J BIOL CHEM, 276(42), 2001, pp. 38830-38836
Authors:
Murillo, H
Huang, HJ
Schmidt, LJ
Smith, DI
Tindall, DJ
Citation: H. Murillo et al., Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state, ENDOCRINOL, 142(11), 2001, pp. 4795-4805
Citation: H. Murillo et al., Tyrphostin AGS25 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2, CANCER RES, 61(20), 2001, pp. 7408-7412
Authors:
Butler, R
Mitchell, SH
Tindall, DJ
Young, CYF
Citation: R. Butler et al., Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-Delta(12,14)-prostaglandin J(2), CELL GROWTH, 11(1), 2000, pp. 49-61
Authors:
Slawin, KM
Shariat, SF
Nguyen, C
Leventis, AK
Song, WT
Kattan, HW
Young, CYF
Tindall, DJ
Wheeler, TM
Citation: Km. Slawin et al., Detection of metastatic prostate cancer using a splice variant-specific reverse transcriptase-polymerase chain reaction assay for human glandular kallikrein, CANCER RES, 60(24), 2000, pp. 7142-7148
Authors:
Spitzweg, C
O'Connor, MK
Bergert, ER
Tindall, DJ
Young, CYF
Morris, JC
Citation: C. Spitzweg et al., Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter, CANCER RES, 60(22), 2000, pp. 6526-6530
Authors:
Black, MH
Magklara, A
Obiezu, C
Levesque, MA
Sutherland, DJA
Tindall, DJ
Young, CYF
Sauter, ER
Diamandis, EP
Citation: Mh. Black et al., Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions, BR J CANC, 82(2), 2000, pp. 361-367
Citation: Dj. Tindall et Pt. Scardino, Defeating prostate cancer: Crucial directions for research-excerpt from the report of the prostate cancer progress review group, PROSTATE, 38(2), 1999, pp. 166-171
Authors:
Charlesworth, MC
Young, CYE
Miller, VM
Tindall, DJ
Citation: Mc. Charlesworth et al., Kininogenase activity of prostate-derived human glandular kallikrein (hK2)purified from seminal fluid, J ANDROLOGY, 20(2), 1999, pp. 220-229
Authors:
Partin, AW
Catalona, WJ
Finlay, JA
Darte, C
Tindall, DJ
Young, CYF
Klee, GG
Chan, DW
Rittenhouse, HG
Wolfert, RL
Woodrum, DL
Citation: Aw. Partin et al., Use of human glandular kallikrein 2 for the detection of prostate cancer: Preliminary analysis, UROLOGY, 54(5), 1999, pp. 839-845
Authors:
Darson, MF
Pacelli, A
Roche, P
Ritttenhouse, HG
Wolfert, RL
Saeid, MS
Young, CYF
Klee, GG
Tindall, DJ
Bostwick, DG
Citation: Mf. Darson et al., Human glandular kallikrein 2 expression in prostate adenocarcinoma and lymph node metastases, UROLOGY, 53(5), 1999, pp. 939-944
Authors:
Zhang, SB
Hsieh, ML
Zhu, W
Klee, GG
Tindall, DJ
Young, CYF
Citation: Sb. Zhang et al., Interactive effects of triiodothyronine and androgens on prostate cell growth and gene expression, ENDOCRINOL, 140(4), 1999, pp. 1665-1671
Authors:
Spitzweg, C
Zhang, SB
Bergert, ER
Castro, MR
McIver, B
Heufelder, AE
Tindall, DJ
Young, CYF
Morris, JC
Citation: C. Spitzweg et al., Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines, CANCER RES, 59(9), 1999, pp. 2136-2141
Authors:
Mikolajczyk, SD
Millar, LS
Marker, KM
Rittenhouse, HG
Wolfert, RL
Marks, LS
Charlesworth, MC
Tindall, DJ
Citation: Sd. Mikolajczyk et al., Identification of a novel complex between human kallikrein 2 and protease inhibitor-6 in prostate cancer tissue, CANCER RES, 59(16), 1999, pp. 3927-3930